CN Stock MarketDetailed Quotes

002262 Jiangsu Nhwa Pharmaceutical

Watchlist
  • 26.00
  • -0.35-1.33%
Not Open Nov 14 15:00 CST
26.42BMarket Cap22.55P/E (TTM)

Jiangsu Nhwa Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Nhwa Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.46B
1.38B
-80.47M
Miss Est.
+16.48%
+10.07%
-5.50%
EPS
0.41
0.39
-0.02
Miss Est.
+20.59%
--
-4.88%
Analyst Rating
Strong Buy

Nov 14, 2024

Jiangsu Nhwa Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.571B--
--2024/Q4-- / 1.652B--
Oct 26, 20242024/Q31.382B / 1.463B--
Jul 31, 20242024/Q21.406B / 1.421B--
Apr 20, 20242024/Q11.358B / 1.380B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.571B--
--2024/Q4-- / 1.652B--
Oct 26, 20242024/Q31.382B / 1.463B--
Jul 31, 20242024/Q21.406B / 1.421B--
Apr 20, 20242024/Q11.358B / 1.380B--

Unlock Free Earnings Estimates

Jiangsu Nhwa Pharmaceutical Earnings Reports

  • Enhua Pharmaceutical: Report for the third quarter of 2024

    Oct 25 12:00 ET

  • Jiangsu Nhwa Pharmaceutical: Half-year report for the year 2024.

    Jul 30 12:00 ET

  • Jiangsu Nhwa Pharmaceutical: Summary of Half-Year Report in 2024.

    Jul 30 12:00 ET

  • Enhua Pharmaceutical: Report for the first quarter of 2024

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Strong Buy

    • Strong Buy

      84.21%

    • Buy

      15.79%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data